Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38 alpha, also known as MAPK14, is a serine/threonine kinase that plays crucial roles in cellular responses to stress stimuli, inflammation, and various physiological processes. It is activated by upstream kinases MKK3 and MKK6 and phosphorylates numerous downstream targets including kinases, transcription factors, and other proteins, influencing cell cycle regulation, apoptosis, synaptic plasticity, inflammation, and muscle function. It is being investigated as a therapeutic target for arthritic and inflammatory diseases, ischemic heart failure, and cardiac regeneration.
Inhibition of p38 alpha kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38 Alpha Mitogen-Activated Protein Kinase (p38 alpha).